US Patent 11590228 Extended release amphetamine compositions
Patent 11590228 was granted and assigned to Tris Pharma on February, 2023 by the United States Patent and Trademark Office.
All edits
US Patent 11590228 Extended release amphetamine compositions
An oral amphetamine extended release liquid suspension is described. The compositions contain a combination of an uncoated amphetamine-cation exchange resin complex, a barrier coated amphetamine-cation exchange resin complex-matrix, and an uncomplexed amphetamine, wherein one or more of these components contains blends of different forms of amphetamines. Either the modified release coated and/or the uncoated amphetamine-cation exchange resin complex may have two forms of amphetamine in a complex with a single cation exchange resin. Following administration of a single dose of the composition, a therapeutically effective amount of amphetamine is reached by about one hour and the composition provides at least a thirteen hour effect post-dose.
Find more entities like US Patent 11590228 Extended release amphetamine compositions
